Option Care Health (OPCH) Stock Overview
Offers home and alternate site infusion services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
OPCH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Option Care Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$27.10 |
| 52 Week High | US$35.53 |
| 52 Week Low | US$21.39 |
| Beta | 0.88 |
| 1 Month Change | -1.67% |
| 3 Month Change | -8.07% |
| 1 Year Change | -12.41% |
| 3 Year Change | -17.68% |
| 5 Year Change | 97.95% |
| Change since IPO | 144.58% |
Recent News & Updates
Why Option Care Health, Inc. (NASDAQ:OPCH) Could Be Worth Watching
Sep 09
Option Care Health: Continued Value Erosion At Current Rate Of Growth
Aug 04Recent updates
Why Option Care Health, Inc. (NASDAQ:OPCH) Could Be Worth Watching
Sep 09Option Care Health: Continued Value Erosion At Current Rate Of Growth
Aug 04An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 43% Undervalued
Jul 25We Think The Compensation For Option Care Health, Inc.'s (NASDAQ:OPCH) CEO Looks About Right
May 08Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Apr 19Why Investors Shouldn't Be Surprised By Option Care Health, Inc.'s (NASDAQ:OPCH) P/E
Mar 18Should You Investigate Option Care Health, Inc. (NASDAQ:OPCH) At US$32.09?
Feb 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 31% Undervaluation?
Jan 23Option Care Health, Inc.'s (NASDAQ:OPCH) Business Is Trailing The Market But Its Shares Aren't
Dec 13Is Option Care Health (NASDAQ:OPCH) Using Too Much Debt?
Nov 28Results: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Oct 17There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Aug 30
Orphan Therapies And Strategic Resilience Propel Company's Year-Over-Year Growth
Diversification into new therapies and engagement with the investment community signal growth and proactive market capture, enhancing future revenue.Option Care Health: Revenue Lines Not Pulling Economic Weight (Rating Downgrade)
Aug 16We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Aug 15What Does Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Indicate?
Jul 15Option Care Health: A Deep Dive Into Its Market Dominance
May 31Option Care Health, Inc.'s (NASDAQ:OPCH) Shareholders Might Be Looking For Exit
May 23We Ran A Stock Scan For Earnings Growth And Option Care Health (NASDAQ:OPCH) Passed With Ease
May 10Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09Shareholder Returns
| OPCH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 1.1% | -1.3% | -1.5% |
| 1Y | -12.4% | -18.1% | 14.4% |
Return vs Industry: OPCH exceeded the US Healthcare industry which returned -19.5% over the past year.
Return vs Market: OPCH underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| OPCH volatility | |
|---|---|
| OPCH Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OPCH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: OPCH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 7,052 | John Rademacher | www.optioncarehealth.com |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
Option Care Health, Inc. Fundamentals Summary
| OPCH fundamental statistics | |
|---|---|
| Market cap | US$4.40b |
| Earnings (TTM) | US$211.25m |
| Revenue (TTM) | US$5.37b |
Is OPCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPCH income statement (TTM) | |
|---|---|
| Revenue | US$5.37b |
| Cost of Revenue | US$4.32b |
| Gross Profit | US$1.06b |
| Other Expenses | US$845.97m |
| Earnings | US$211.25m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 30, 2025
| Earnings per share (EPS) | 1.30 |
| Gross Margin | 19.67% |
| Net Profit Margin | 3.93% |
| Debt/Equity Ratio | 81.6% |
How did OPCH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/16 04:32 |
| End of Day Share Price | 2025/10/16 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Option Care Health, Inc. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Richard Close | Canaccord Genuity |